FDA Inspection 1230725 — OneBlood, Inc.
The FDA completed an inspection of OneBlood, Inc. on February 15, 2024 in Melbourne, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 15, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Melbourne, FL (United States)